The Cancer Genome Atlas (TCGA) research reported that overexpression of miR-21 is associated with hypomethylation of the MIR21 promoter in clear cell renal cell carcinoma (ccRCC)10 and papillary thyroid carcinoma (PTC).11 Here, MIR21 is linked to nonpapillary renal cell carcinoma.